Coherus Biosciences | CHRS - 普通股股本



金融业
股票价格
USD
资产
USD 258.34M
现金及等价物
USD 88.88M
销售成本
USD 4.05M
流动资产
USD 206.71M
流动负债
USD 140.39M
债务
USD 294.93M
股息收益率
0
EBIT
USD -39.08M
EBITDA
USD -43.33M
员工
306
EPS每股收益
USD -0.43
股本和储备
USD 61.01M
销售毛利
USD 8.7M
债务利息支出
USD 2.25M
贷款资金
USD 51.08M
市值
USD 198.9M
净收入
USD -37.64M
营业费用
USD 51.83M
营业利润
USD -39.08M
普通股股本
USD 121.16M
税前利润
USD -46.35M
销售收入
USD 12.75M
销售和管理费用
USD 15M
股票
USD 3.17M
贸易债权人
USD 9.92M
应收帐款人
USD 18.42M


普通股股本 更改 日
AbbVie USD 1.77B 1.75B 2025-06
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Akebia Therapeutics USD 265.42M 199K 2025-12
ALKERMES USD 165.61M 503K 2025-12
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Amarin USD 20.81M 13K 2025-12
Amgen USD 540M 1000K 2026-03
Baxter International USD 516.45M 2.17M 2026-03
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Fujifilm JPY 1.21B 19K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
Merck USD 2.47B 12.72M 2025-12
Myriad Genetics USD 93.5M 400K 2025-12
Pacira USD 39.31M 1.81M 2026-03
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 0 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Sarepta Therapeutics USD 104.96M 196K 2025-12
Teva Pharmaceutical Industries USD 1.16B 16.72M 2026-03
Vertex Pharmaceuticals USD 254.2M 200K 2026-03
Xencor USD 71.87M 529K 2025-12
Zoetis USD 424.93M 16.54M 2025-12